Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Key Findings: Most common: Nausea (43%), diarrhea (33%), vomiting (21%) Unique to retatrutide: Dysesthesia (20.9% @ 12mg in TRIUMPH-4, 8.8% @ 9mg) Discontinuation rate: 18.2% in TRIUMPH-4, 11.3% in TRIUMPH-1 (general obesity population) compared to semaglutide 6.9%, tirzepatide 6.2% Good news: Most side effects peak during dose escalation and improve significantly after week 16 Management: Slow titration, dietary modifications, and proper timing dramatically reduce severity Understanding the Three Categories of Side Effects 1
The entire process takes place online, which makes it convenient for people with busy schedules or limited access to in-person healthcare
Discussion This observational cohort study describes real-world utilization patterns and characteristics of patients dispensed an SGLT2i or GLP-1 RA in the US using data from Optum CDM in the period following changes to the landscape for treatment and prevention of CKD in type 2 diabetes (later period, July 2021September 2023) as well as temporal changes in utilization and baseline characteristics relative to the period prior (earlier period, January 2012June 2021)
This may include diagnosis and labs to determine eligibility
Since then, Dr Sinclair has seen and heard of other patients who have become ill after taking so-called retatrutide, including a woman who presented to emergency at the Austin a few weeks ago in acute liver failure
Parasympathetic efferent nerves can transmit neuropeptides and acetylcholine to the islet liver, increasing insulin release and liver NO production through muscarinic receptors and lowering blood sugar
US$ 25.20
US$ 22.15
US$ 28.78
